Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs

Epilepsia

Volumn 49, Issue SUPPL. 9, 2008, Pages 63-73

  Wasterlain, Claude G ^a,b   Chen, James W Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acute seizures; GABAA receptors; Ketamine; Levetiracetam; NMDA receptors; Receptor trafficking; Status epilepticus; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; DELTA OPIATE RECEPTOR AGONIST; DIAZEPAM; DYNORPHIN; ETIRACETAM; FELBAMATE; FOSPHENYTOIN SODIUM; GALANIN; KAINIC ACID RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; KETAMINE; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE Y; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; SODIUM CHANNEL BLOCKING AGENT; SOMATOSTATIN; SUBSTANCE P; TACHYKININ RECEPTOR ANTAGONIST; THIOPENTAL; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID;

AGGRESSIVENESS; ALGORITHM; ANTICONVULSANT ACTIVITY; CONTINUOUS INFUSION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; EMERGENCY TREATMENT; EPILEPTIC STATE; EPILEPTOGENESIS; HUMAN; HYPOTENSION; LIVER TOXICITY; LOADING DRUG DOSE; MENTAL DISEASE; NEUROPATHOLOGY; NONHUMAN; PANCREATITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; SOMNOLENCE; THROMBOCYTOPENIA;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; HUMANS; STATUS EPILEPTICUS;

EID: 57349191100     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01928.x     Document Type: Review

References (93)

1. Abend NS, Florance N, Finkel RS, Licht DJ, Dlugos DJ 2008) Intravenous levetiracetam terminates refractory focal status epilepticus. Neurocrit Care 7 : 9044 9049.
2. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N 2007) Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 16 : 527 532.
3. Alehan F, Ozcay F, Haberal F 2008) The use of levetiracetam in a child with nonconvulsive status epilepticus. J Child Neurol 23 : 331 333.
4. Atefy R, Tettenborn B 2005) Nonconvulsive status epilepticus on treatment with levetiracetam. Epilepsy Behav 6 : 613 616.
5. Bensalem MK, Fakhoury TA 2003) Topiramate and status epilepticus: report of three cases. Epilepsy Behav 4 : 757 760.
6. Bleck TP, Quogg M, Nathan BR, Smith TL, Kapur J 2002) Electroencephalographic effects of ketamine treatment for refractory status epilepticus. Epilepsia 43 : 282.
7. Blumkin L, Lerman-Sagie T, Houri T, Gilad E, Nissenkorn A, Ginsberg M, Watemberg N 2005) Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol 20 : 239 241.
8. Chen JW, Wasterlain CG 2006) Status epilepticus: pathophysiology and management in adults. Lancet Neurol 5 : 246 256.
9. Clark LP, Prout TP (1903) Status epilepticus: a clinical and pathological study in epilepsy [An article in 3 parts]. Am J Insanity 60 : 291 306 60 : 645 75 61 : 81 108.
10. DeLorenzo RJ, Garnett LK, Towne AR 1999) Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 40 : 164 169.
11. Embacher N, Karner E, Wanschitz J, Beer R, Trinka E 2006) Acute encephalopathy after intravenous administration of valproate in non-convulsive status epilepticus. Eur J Neurol 13 : e5 e6.
12. Epilepsy Foundation of America 1993) Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 70 : 854 859.
13. Farooq MU, Naravetla B, Majid A, Gupta R, Pysh JJ, Kassab MY 2007) IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit Care 7 : 36 39.
14. Fujikawa DG 1996) The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res 725 : 11 22.
15. Gastaut H 1983) Classification of status epilepticus. Adv Neurol 34 : 15 35.
16. George B, Kulkarni SK 1996) Protective effects of GABAergic drugs and other anticonvulsants in lithium-pilocarpine-induced status epilepticus. Methods Find Exp Clin Pharmacol 18 : 335 340.
17. Gibbs JE, Walker MC, Cock HR 2006) Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia 47 : 469 478.
18. Giroud M, Gras D, Escousse A, Dumas R, Venaud G 1993) Use of injectable valproic acid in status epilepticus. Drug Invest 5 : 154 159.
19. A receptors. J Neurosci 25 : 5511 5520.
20. A receptors during status epilepticus. J Neurosci 28 : 2527 2538.
21. Goraya JS, Khurana DS, Valencia I, Melvin JJ, Cruz M, Legido A, Kothare SV 2008) Intravenous levetiracetam in children with epilepsy. Pediatr Neurol 38 : 177.
22. Hirsch LJ, Claassen J 2002) The current state of treatment of status epilepticus. Curr Neurol Neurosci Rep 2 : 345 356.
23. Hönack D, Löscher W 1992) Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin. Epilepsy Res 13 : 215 221.
24. A receptors is transcriptionally controlled by the interplay of cAMP-response element-binding protein and its binding partner inducible cAMP early repressor. J Biol Chem 283 : 9328 9340.
25. Jha S, Jose M, Patel R 2003) Intravenous sodium valproate in status epilepticus. Neurol India 51 : 421 422.
26. Kahriman M, Minecan D, Kutluay E, Selwa L, Beydoun A 2003) Efficacy of topiramate in children with refractory status epilepticus. Epilepsia 44 : 1353 1356.
27. A receptors. J Neurosci 17 : 7532 7540.
28. Kim JS, Kondratyev A, Tomita Y, Gale K 2007) Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 48 (Suppl 5 19 26.
29. Klitgaard H, Matagne A, Gobert J, Wulfert E 1999) Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 353 : 191 206.
30. Klitgaard H, Matagne A, Grimee R, Vanneste-Goemaere J, Margineanu DG 2003) Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy. Seizure 12 : 92 100.
31. Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, Hamer HM 2008) Intravenous levetiracetam in the treatment of benzodiazepine-refractory status epilepticus. J Neurol Neurosurg Psychiatry 79 : 588 589.
32. Knorr M, Schaper J, Harjes M, Mayatepek E, Rosenbaum T 2004) Fanconi syndrome caused by antiepileptic therapy with valproic Acid. Epilepsia 45 : 868 871.
33. Krähenbühl S, Brandner S, Kleinle S, Liechti S, Straumann D 2000) Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 20 : 346 348.
34. Kroll-Seger J, Mothersill IW, Novak S, Salke-Kellerman RA, Kramer G 2006) Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report (2006). Epileptic Disord 8 : 213 218.
35. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG 2005) Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 64 : 353 355.
36. Maggi JD, Halman MH 2007) The effect of divalproex sodium on HIV replication in vivo. J Neuropsychiatry Clin Neurosci 19 : 326 330.
37. Marini H, Costa C, Passaniti M, Esposito M, Campo GM, Ientile R, Adamo EB, Marini R, Calabresi P, Altavilla D, Minutoli L, Pisani F, Squadrito F 2004) Levetiracetam protects against kainic acid-induced toxicity. Life Sci 74 : 1253 1264.
38. Martín ED, Pozo MA 2003) Valproate suppresses status epilepticus induced by 4-aminopyridine in CA1 hippocampus region. Epilepsia 44 : 1375 1379.
39. Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG 1998) Time dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 814 : 179 185.
40. Mazarati AM, Wasterlain CG 1999) NMDA receptors antagonists abolish the maintenance phase of self-sustaining status epilepticus. Neurosci Lett 65 : 187 190.
41. Mazarati AM, Baldwin R, Klitgaard H, Matagne A, Wasterlain CG 2004) Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res 58 : 167 174.
42. Mehta V, Singhi P, Singhi S 2007) Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol 22 : 1191 1197.
43. Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, Holtkamp M 2006) EFNS guideline on the management of status epilepticus. Eur J Neurol 13 : 445 450.
44. Mewasingh LD, Sékhara T, Aeby A, Christiaens FJ, Dan B 2003) Oral ketamine in paediatric non-convulsive status epilepticus. Seizure 12 : 483 489.
45. Minicucci F, Muscas G, Perucca E, Capovilla G, Vigevano F, Tinuper P 2006) Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy. Epilepsia 47 (Suppl 5 9 15.
46. Misra UK, Kalita J, Patel R 2006) Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 25 67 : 340 342.
47. Morrisett RA, Jope RS, Snead OC 3rd. 1987) Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of piloarpine to lithium-pretreated rats. Exp Neurol 97 : 193 200.
48. Naylor DE, Wasterlain CG 2005) GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant path stimulation. Epilepsia. 46 (S5 142 147.
49. Naylor DE, Liu H, Wasterlain CG 2005) Trafficking of GABAA receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 25 : 7724 7733.
50. Olsen KB, Taubøll E, Gjerstad L 2007) Valproate is an effective, well-tolerated drug for treatment of status epilepticus/serial attacks in adults. Acta Neurol Scand Suppl 187 : 51 54.
51. Patel R, Jha S 2004) Intravenous valproate in post-anoxic myoclonic status epilepticus: a report of ten patients. Neurol India 52 : 394 396.
52. Perry MS, Holt PJ, Sladky JT 2003) Topiramate loading for refractory status epilepticus in children. Epilepsia 47 : 1070 1071.
53. Peters CN, Pohlmann-Eden B 2005) Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus - experience in 102 adult patients. Seizure 14 : 164 169.
54. Pustorino G, Spano M, Sgro DL, Di Rosa G, Tricomi G, Bellantone D, Tortorella G 2007) Status gelasticus associated with levetiracetam as add-on treatment. Epileptic Disord 9 : 186 189.
55. Reuber M, Evans J, Bamford JM 2002) Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol 9 : 111 112.
56. Riban V, Bouilleret V, Pham-Lê BT, Fritschy JM, Marescaux C, Depaulis A 2002) Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112 : 101 111.
57. van Rijckevorsel K, Boon P, Hauman H, Legros B, Ossemanns M, Sadzot B, Schmedding E, van Zandijcke M 2005) Standards of care for adults with convulsive status epilepticus: Belgian consensus recommendations. Acta Neurol Belg 105 : 111 118.
58. van Rijckevorsel K, Boon P, Hauman H, Legros B, Ossemann M, Sadzot B, Schmedding E, van Zandijcke M 2006) Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations. Acta Neurol Belg 106 : 117 124.
59. Rossetti AO, Bromfield EB 2006) Levetiracetam in the treatment of status epilepticus: a study of 13 episodes. Eur Neurol 54 : 34 38.
60. Rossetti AO 2007) Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 68 : 70.
61. Ruegg S, Naegelin Y, Hardmeier M, Winkler DT, Marsch S, Fuhr P 2008) Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 12 : 477 480.
62. Rupprecht S, Franke K, Fitzek S, Witte OW, Haemann G 2007) Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 73 : 238 244.
63. Schulze-Bonhage A, Hefft S, Oehl B 2007) Termination of complex partial status epilepticus by intravenous levetiracetam: a case report. J Neurol Neurosurg Psychiatry March 12 [Epub ahead of print].
64. Schwabe MJ, Dobyns WB, Burke B, Armstrong DL 1997) Valproate-induced liver failure in one of two siblings with Alpers disease. Pediatr Neurol 16 : 337 343.
65. Shahar E, Andraus J, Sagie-Lerman T, Savitzki D 2002) Valproic acid therapy inducing absence status evolving into generalized seizures. Pediatr Neurol 26 : 402 404.
66. Sheth RD, Gidal BE 1998) Refractory status epilepticus: response to ketamine. Neurology 51 : 1765 1766.
67. Sheth RD, Gidal BE 2000) Intravenous valproic acid for myoclonic status epilepticus. Neurology 54 : 1201.
68. Shorvon S 1994) Status epilepticus: its clinical features and treatment in children and adults. University Press, Cambridge.
69. Sinha S, Naritoku DK 2000) Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 55 : 722 724.
70. Sofia RD, Gordon R, Gels M, Diamantis W 1993) Effects of felbamate and other anticonvulsant drugs in two models of status epilepticus in the rat. Res Commun Chem Pathol Pharmacol 79 : 335 341.
71. Spriet I, Meersseman W, De Troy E, Wilmer A, Casteels M, Willems L 2007) Meropenem-valproic acid interaction in patients with cefepime-associated status epilepticus. Am J Health Syst Pharm 64 : 54 58.
72. Theodore WH, Porter RJ, Albert P, Kelley K, Bromfield E, Devinsky O, Sato S 1994) The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology 44 : 1403 1407.
73. Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ 2003). The use of topiramate in refractory status epilepticus. Neurology 28 60 : 332 334.
74. Trabacca A, Profice P, Costanza MC, Gesualdi M, De Rinaldis M 2007) Levetiracetam in nonconvulsive status epilepticus in childhood: a case report. J Child Neurol 22 : 639 641.
75. Treiman DM, Meyers PD, Walton NY 1998) A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 339 : 792 798.
76. Trinka E 2007) The use of valproate and new antiepileptic drugs in status epilepticus. Epilepsia 48 (Suppl 8 49 51.
77. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA 1989) Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3 : 154 171.
78. Uberall MA, Trollmann R, Wunsiedler U, Wenzel D 2000) Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 54 : 2188 2189.
79. Ubogu EE, Sagar SM, Lerner AJ, Maddux BN, Suarez JI, Werz MA 2003) Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav 4 : 70 75.
80. Vajda FJ, Hitchcock A, Graham J, O'Brien T, Lander C, Eadie M 2007) The Australian register of antiepileptic drugs in pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 47 : 468 474.
81. Veldkamp AI, Swart EL 2006) Unanticipated recovery from a status epilepticus after administration of levetiracetam. Br J Clin Pharmacol 62 : 734 735.
82. Velioǧlu SK, Gazioǧlu S 2007) Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy. Acta Neurol Scand 116 : 128 132.
83. Venkataraman V, Wheless JW 1999) Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 35 : 147 153.
84. Vicedomini JP, Nadler JV 1987) A model of status epilepticus based on electrical stimulation of hippocampal afferent pathways. Exp Neurol 96 : 681 691.
85. Walton NY, Treiman DM 1992) Valproic acid treatment of experimental status epilepticus. Epilepsy Res 12 : 199 205.
86. Wasterlain CG, Liu H, Mazarati A, Baldwin RA 2002a) NMDA receptor trafficking during the transition from single seizures to status epilepticus. Ann Neurol 52 : S16.
87. Wasterlain CG, Mazarati AM, Naylor D, Niquet J, Liu H, Suchomelova L, Baldwin R, Katsumori H, Shirasaka Y, Shin D, Sankar R 2002b) Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus. Epilepsia 43 (Suppl 5 20 29.
88. Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, Morton L, Pellock JM 2004) Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 26 63 : 1507 1508.
89. Wasterlain CG, Chen J 2006) Definition and classification of status epilepticus. In Wasterlain CG, Treiman DM (Eds) Status epilepticus. MIT Press, Boston, pp. 11 16.
90. Wasterlain CG, Treiman DM, Eds 2006) Status epilepticus: mechanisms and management. MIT Press, Boston.
91. White JR, Santos CS 1999) Intravenous valproate associated with significant hypotension in the treatment of status epilepticus. J Child Neurol 14 : 822 823.
92. Yu KT, Mills S, Thompson N, Cunanan C 2003) Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 44 : 724 726.
93. Zaatreh MM 2005) Levetiracetam in porphyric status epilepticus: a case report. Clin Neuropharmacol 28 : 243 244.